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Highlights 
 
 Major depression is being investigated in relation with neurodegenerative processes occurring in 
different sites, such as retinal degeneration 
 OCT has allowed us to improve our knowledge about retinal morpholology and anatomy, giving a 
thee-dimensional visualization of all the single retinal layers 
 Many confounding factors may influence retinal volume and thickness; retinal diurnal variation has 
been described in literature 
 When measuring retina by OCT an optical biometry examination should be performed in order to 
evaluate axial length 
 Antidepressant drugs exerts important  ocular side effects and therefore should be considered as  
important confounding factors   
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Abstract: The aim of this article is to underline the importance of all the possible confounding 
factors involved in the variation of retinal thickness. More in detail, antidepressant drugs represent 
an important confounding factor that should not be neglected when measuring retinal thickness by 
Spectral Domain Optical Coherence Tomography (SD-OCT) in patients with major depressive 
disorder 
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To the Editor, 
 
We read with interest the article entitled “Retinal changes in patients with major depressive disorder 
– A controlled optical coherence tomography study” recently published by Schönfeldt-Lecuona et 
al. 
1
 in your journal. 
In this study the authors analyzed the overall retinal thickness and five different retinal layers in 
patients with major depressive disorder by using Spectral- Domain- Optical Coherence 
Tomography (SD-OCT) and compared the results with age-matched healthy subjects. In this regard, 
the authors should be congratulated for having studied first, to the best of our knowledge, every 
retinal single layer in patients with majore depressive (MD) disorder and , nonetheless, for having 
reported a small but significant difference in total retinal thickness between the two eyes in the 
examined group, differently from the control group 
1
. 
However, we would like to raise some methodological concerns from an ophthalmologic point of 
view. Firstly, the authors did not clarify if they performed the OCT examination at the same part of 
the day for both the patients with MD and healthy subjects; in this regard, it has been reported that 
retinal thickness can be subjected to small but statistically significant diurnal variations 
2,3
. Thus, we 
deem that more precise information about the timing of the examination should have been provided, 
especially not neglecting the possible difference between the examined and the control group. 
Secondly, they did not specify if the complete ophthalmological examination, beside the slit lamp 
examination combined with indirect ophthalmoscopy, tonometry and refraction,  included also 
optical biometry with the measurements of important ocular parameters such as axial length (AL) . 
In fact, extrapolated data from the Beijing Eye Study has shown in multivariate analysis that an 
increase in central foveal thickness was positively associated with a longer AL
4
. Moreover, another 
prospective study demonstrated not only the positive correlation between AL and total retinal 
thickness, but also with single retinal layers like the ganglion cell and inner plexiform layer 
complex (GCL+IPL), the  inner nuclear layer (INL) and outer plexiform layer (OPL)
5
 . Hence, 
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when measuring retinal thickness by SD-OCT, it should be suggested to perform an optical 
biometry examination in order to rule out important confounding factors such as AL. 
Thirdly, the authors did not report in the exclusion criteria the smoking status of the subjects. 
However, Dervisigullari et al. revealed in smokers subjects the presence of a thinner retina nerve 
fiber layer (RNFL) in comparison with age-matched non-smokers subjects 
6
. Thus, we deem that 
also a screening for smoking status should have been provided by the authors in order to adjust 
another possible confounding factor. 
Lastly, we think that the administration of antidepressant therapy in the examined group could have 
altered the results in this study. In fact, it is well known that tricyclic antidepressants (TCAs) are 
responsible for several ocular side effects due to their anticholinergic effect, including cycloplegia, 
mydriasis and uveal tract disorders. Moreover, also a case of maculopathy induced by sertraline, a 
selective serotonin reuptake inhibitor (SSRI)  antidepressant drug, has been previously documented 
in the literature 
7
. In conclusion, given this evidence, it cannot be excluded  that the results reported 
by the authors could have been influenced by the administration of antidepressant drugs in the 
examined group and therefore this could represent an important and not negligible limitation of the 
study. In the near future, further studies should be carried out in order to better define the boundary 
between the effect exerted by antidepressant drugs and by the depressive disorder itself on the eye 
and in particular on retina. 
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